XOStem
Chad Friesen has worked in a variety of roles since 1995. Chad began their career at TELUS, where they served as a Sr. Operations Manager. In 2011, they became a Resident of North Vancouver and an International New Business Consultant. Chad then worked as a Wealth Management Marketing for Assante Wealth Management. In 2020, they took on the role of Director at XOStem, Inc. and in 2021 they became the Founder and CEO of HIVE Investment.
Chad Friesen obtained a Master of Business Administration (M.B.A.) in Marketing from Queen's University between 2011 and 2012. Chad also attended The University of British Columbia from 1999 to 2005, studying Economics and Sociology. Lastly, they attended the Sauder school of business for Governance.
This person is not in any teams
This person is not in any offices
XOStem
XOStem is the stem cell expert that creates the next generation treatment for Type 1 Diabetes and produces Engineered Exosomes.